Yüklüyor......
Effect of Tyrosin Kinase Inhibitors on NK Cell and ILC3 Development and Function
Tyrosin kinase inhibitors (TKI) sharply improved the prognosis of Chronic Myeloid Leukemia (CML) and of Philadelphia(+) Acute Lymphoblastic Leukemia (Ph(+)ALL) patients. However, TKI are not curative because of the development of resistance and lack of complete molecular remission in the majority of...
Kaydedildi:
| Yayımlandı: | Front Immunol |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6207002/ https://ncbi.nlm.nih.gov/pubmed/30405627 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.02433 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|